Published 4 issues per year
ISSN Print: 0893-9675
ISSN Online: 2162-6448
Indexed in
Genomic Pathology and Cancer Biomarkers: Prostate Cancer
ABSTRACT
Our understanding of genomic pathology and biomarkers for prostate cancer is continually growing. Some promising and useful tissue markers are GSTP1, HOXD3, cell cycle proteins, chromatin remodeling proteins, androgen receptor, Stat5a/b, ERG, and PTEN. Serum and urine markers are mostly either prostate-specific antigen or newer tests using one or more other kallikreins or sarcosine. The data and evidence for all of these markers and the commercial tests using them are reviewed here.
-
Liu Duo, Zhu Jingjing, Zhou Dan, Nikas Emily G., Mitanis Nikos T., Sun Yanfa, Wu Chong, Mancuso Nicholas, Cox Nancy J., Wang Liang, Freedland Stephen J., Haiman Christopher A., Gamazon Eric R., Nikas Jason B., Wu Lang, A transcriptome‐wide association study identifies novel candidate susceptibility genes for prostate cancer risk, International Journal of Cancer, 150, 1, 2022. Crossref
-
Garcia‐Marques Fernando, Liu Shiqin, Totten Sarah M., Bermudez Abel, Tanimoto Cheylene, Hsu En‐Chi, Nolley Rosalie, Hembree Amy, Stoyanova Tanya, Brooks James D., Pitteri Sharon J., Protein signatures to distinguish aggressive from indolent prostate cancer, The Prostate, 82, 5, 2022. Crossref